Camurus Overview

  • Founded
  • 1991

Founded
  • Status
  • Public

  • Employees
  • 170

Employees
  • Stock Symbol
  • CAMX

Stock Symbol
  • Share Price
  • $26.62

  • (As of Wednesday Closing)

Camurus General Information

Description

Camurus AB is a research and development focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical segments include Europe (of which Sweden), the United States, Japan, Australia, and Other geographical areas.

Contact Information

Website
www.camurus.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Ideon Science Park
  • 223 70 Lund
  • Sweden
+46 046-286 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Camurus Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$26.62 $25.92 $12.88 - $26.68 $1.46B 55.4M 88.1K $0.05

Camurus Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 1,244,431 868,206 1,181,983 449,717
Revenue 90,107 69,932 36,441 11,165
EBITDA 4,900 (11,399) (21,006) (37,111)
Net Income 2,945 (10,532) (18,141) (30,646)
Total Assets 110,677 119,549 127,281 82,575
Total Debt 2,255 2,835 3,106 2,923
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Camurus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Camurus‘s full profile, request access.

Request a free trial

Camurus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Camurus AB is a research and development focused pharmaceutical company. It develops pharmaceuticals for the treatment o
Drug Discovery
Lund, Sweden
170 As of 2022
000.00
000000000 000.00

000000

unt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco lab
000000000000000
Copenhagen, Denmark
0000 As of 0000
00000000

000000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
0000 000000000
Rockville, MD
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Camurus Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lundbeck Corporation Copenhagen, Denmark 0000 00000000
00000000 000000000 Formerly VC-backed Rockville, MD 000 00000 00000000000 00000
000000 00000000 Corporation Tokyo, Japan 00000 00.000 00000000 00.000
00000 000000000000 Formerly VC-backed Washington, DC 000 00000 000000&0
000000000 00000000 Formerly VC-backed Lund, Sweden 00 00000 000000000 00000
You’re viewing 5 of 34 competitors. Get the full list »

Camurus Patents

Camurus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202003998-D0 Ped5 modulator formulations Inactive 19-Mar-2020
AU-2020342591-A1 Formulations and treatment methods Pending 02-Sep-2019 0000000000
EP-4025184-A1 Formulations and treatment methods Pending 02-Sep-2019 0000000000
US-20220288061-A1 Formulations and treatment methods Pending 02-Sep-2019 0000000000
US-20220202898-A1 Lipid-controlled release compositions Pending 29-May-2019 A61K9/1274
To view Camurus’s complete patent history, request access »

Camurus Executive Team (7)

Name Title Board Seat Contact Info
Fredrik Tiberg Ph.D Chief Executive Officer & Board Member
Jon Garay Alonso Chief Financial Officer
Fredrik Joabsson Ph.D Chief Business Development Officer
Richard Jameson Chief Commercial Officer
Torsten Malmström Ph.D Chief Technical Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Camurus Board Members (4)

Name Representing Role Since
0000000 0000000 Camurus Board Member 000 0000
0000000 000000 00. Camurus Chief Executive Officer & Board Member 000 0000
0000 000000000 Camurus Board Member 000 0000
0000000 0000000000 Camurus Board Member 000 0000
To view Camurus’s complete board members history, request access »

Camurus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Camurus Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Camurus‘s full profile, request access.

Request a free trial